|
市場調査レポート
商品コード
1126392
術中イメージングの世界市場規模、シェア、産業動向分析レポート:最終用途別、コンポーネント別、製品別、用途別、地域別展望・予測、2022年~2028年Global Intraoperative Imaging Market Size, Share & Industry Trends Analysis Report By End-use, By Component, By Product, By Application, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
術中イメージングの世界市場規模、シェア、産業動向分析レポート:最終用途別、コンポーネント別、製品別、用途別、地域別展望・予測、2022年~2028年 |
出版日: 2022年08月31日
発行: KBV Research
ページ情報: 英文 283 Pages
納期: 即納可能
|
世界の術中イメージング市場規模は、2028年までに38億米ドルに達し、予測期間中にCAGR6.3%の市場成長率で上昇すると予測されています。
がんや心血管疾患などの慢性疾患の有病率の増加により、手術の実施件数が増加しており、これが術中イメージング市場の拡大を後押ししています。例えば、米国臨床腫瘍学会(ASCO)は、2022年2月に米国で男性14,170人、女性10,880人を含む25,050人が脳・脊髄腫瘍で発見されると予想していると報告しています。
COVID-19のインパクト分析
術中イメージング市場は、COVID-19の発生により深刻な影響を受けています。製造およびサプライチェーンにおいて、市場は顧客へのタイムリーな製品供給や、業界で提供されている商品やサービスに対する需要の不一致などの問題に対処しなければなりません。診断テストを実施・研究する資格を持つ研究所の人材不足、大半の業界における業務制限、研究・学術機関への資金不足などが、顧客への術中イメージング製品の供給量減少の原因となっています。
市場成長の要因
術中イメージングモダリティの技術的向上
術中イメージングでは、特殊な画像処理技術やポータブル/ハンドヘルド/スマートフォンベースの術中イメージング機器の登場など、医療機器業界において過去10年間に大きな変化と技術的なブレークスルーが見られました。従来のイメージング機器に比べ、技術的に洗練された術中イメージングシステムは、迅速なパフォーマンス、より良い画質、シンプルなコンソール、より簡単な操作を実現しています。
世界の高齢者人口の増加
高齢化は、労働市場や金融市場、交通、住宅、社会保障などの製品やサービス、さらには家族構成や世代間のつながりなど、社会のほぼすべての側面に影響を及ぼすため、21世紀における最も大きな社会変化のひとつとなることが予想されます。健康は、物理的・社会的環境から直接、あるいは選択、機会、健康行動に影響を与える制約や報酬を介して影響を受ける可能性があります。
市場抑制要因
術中イメージングシステムに関連する膨大なコスト
術中イメージングシステムの価格と設置費用は相当なものであり、患者の手術費用を引き上げています。特に発展途上国では、医療機関の大半がこのような技術を導入する余裕がないため、新しいシステムの導入速度に影響を与えます。また、医療機関が高額なシステムを導入する場合、その診断・治療費用を第三者支払機関に依存することが多いです。
製品別の展望
術中イメージング市場は、製品によって、術中超音波、術中CT、術中MRI、Cアームシステムに分類されます。2021年の術中イメージング市場では、術中超音波部門が大きな収益シェアを獲得しました。ダイナミックイメージング技術である術中超音波(IOUS)により、外科手術中、インタラクティブで迅速なデータの流れが提供されます。トランスデューサーが調査対象の臓器に直接触れるため、空気、骨、周囲の軟組織の影響を受けない高解像度の画像を作成することができます。
最終用途の展望
術中イメージング市場は、エンドユーザー別に病院とその他に区分されます。病院セグメントは、2021年に術中イメージング市場で最高の収益シェアを獲得しました。これは、病院が患者の転帰を改善するために、最先端の術中イメージング装置を導入するケースが増えているためです。例えば、3.0T高磁場術中MRI装置を採用した初の脳切除症例は、2019年4月に玄武病院脳神経外科中国が行い、精密脳神経外科の新時代が始まったことが示唆されています。
コンポーネント別の展望
術中イメージング市場は、コンポーネント別に、システム、ソフトウェア、サービスに細分化されます。2021年の術中イメージング市場では、システム部門が最大の収益シェアを記録しました。これは、様々な最新のヘルスケア技術やソリューションの採用に対する政府による投資の増加によるものです。これらのシステムは、手術周辺のワークフローの要求を満たすために開発されています。さらに、これらのシステムは、頭蓋、脊椎、整形外科を含む幅広いプロセスで利用されています。
アプリケーションの展望
術中イメージング市場は、用途に応じて、脳神経外科、整形外科、耳鼻咽喉科、腫瘍外科、外傷外科/救急室、心臓血管、その他に分類されます。2021年の術中イメージング市場では、脳神経外科分野が最も高い収益シェアを調達しました。術中イメージングの成果は、脳神経外科医がより高い精度で手術を行い、余分な処置の必要性を減らし、手術室への出入りの際に患者を感染から保護するため、画期的なものです。
地域別の展望
地域別では、北米、欧州、アジア太平洋、LAMEAで術中イメージング市場を分析しています。北米は、2021年の売上高シェアが最大で、術中イメージング市場の主要地域となっています。重要なエンドユーザーの間で術中イメージング技術が大幅に採用され、術中イメージング製品のメーカーと販売業者の流通網がかなり充実していることから、北米は成熟した市場となっています。
市場参加者がとる主な戦略は、パートナーシップです。カーディナルマトリックスで紹介した分析によると、術中イメージング市場ではシーメンス・ヘルスマイヤーズAGが先駆者です。Stryker Corporation、Medtronic plc、Koninklijke Philips N.V.などの企業は、術中イメージング市場における主要な革新的企業の一部です。
List of Figures
The Global Intraoperative Imaging Market size is expected to reach $3.8 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.
During surgery, the surgeon uses the intraoperative imaging system, an optical imaging device, to obtain a fast and detailed image of the surgical site. Through the use of images of the organ, tissue, or cell that the surgeon will be operating on, intraoperative imaging assists the surgeon. Intraoperative ultrasound, intraoperative X-ray, intraoperative MRI, intraoperative CT, and mobile C-arm are a few examples of intraoperative imaging equipment.
These tools are utilized in a variety of surgical operations, including gastrointestinal surgery, heart surgery, neurosurgery, and cancer surgery. The market is growing as a result of improvements in intraoperative imaging devices and the use of these technologies in hospitals and ambulatory surgical centres for better surgical outcomes. Additionally, the government's efforts to advance the healthcare sector spur market expansion.
Increased prevalence of chronic conditions like cancer and cardiovascular illnesses results in more surgeries being performed, which fuels the intraoperative imaging market's expansion. For example, the American Society of Clinical Oncology (ASCO) reported that 25,050 persons, including 14,170 men and 10,880 women, are expected to be detected with brain and spinal cord tumours in the United States in February 2022.
COVID-19 Impact Analysis
The intraoperative imaging market has been severely impacted by the COVID-19 outbreak. In the manufacturing and supply chain, the market must address issues including timely product delivery to customers and inconsistent demand for the goods and services offered in the industry. A lack of qualified lab personnel to perform/study diagnostic tests, restricted operations in the majority of industries, insufficient funding for research and academic institutions, have all contributed to the decreased availability of intraoperative imaging products to customers.
Market growth Factors
Technological Improvements within Intraoperative Imaging Modalities
Intraoperative imaging has seen considerable changes and technological breakthroughs over the past ten years in the medical device industry, including the emergence of specialized imaging technologies as well as portable/handheld/smartphone-based intraoperative imaging equipment. Comparatively to conventional imaging devices, technologically sophisticated intraoperative imaging systems provide quick performance, better image quality, simpler consoles, and easier operations.
Growing Population of Elderly People across the Globe
With consequences for almost all facets of society, which include the labour and financial markets, the demand for products and services like transportation, housing, and social protection, in addition to family structures and intergenerational ties, population ageing is prepared to be one of the most massive social evolutions of the twenty-first century. Health can be impacted by physical and social settings directly or via restrictions or rewards that influence choices, opportunities, and health behaviours.
Market Restraining Factors
Huge Cost Associated With the Intraoperative Imaging Systems
The price of and installation costs for intraoperative imaging systems are considerable, which raises the cost of the patient's procedure. This has an impact on how quickly new systems are adopted, particularly in developing nations where the majority of healthcare facilities cannot afford these technologies. When healthcare organizations invest in such expensive systems, they frequently rely on third-party payers to cover the expenses of diagnostic and therapeutic operations carried out using these systems.
Product Outlook
Based on Product, the intraoperative imaging market is classified into Intraoperative Ultrasound, Intraoperative CT, Intraoperative MRI and C-arm System. Intraoperative Ultrasound segment acquired a significant revenue share in the intraoperative imaging market in 2021. An interactive and rapid stream of data is provided by intraoperative ultrasound (IOUS), a dynamic imaging technique, throughout surgical procedures. High-resolution images which are unaffected by air, bone, or surrounding soft tissues can be produced since the transducer is in direct touch with the organ being studied.
End-use Outlook
On the basis of end-use, the intraoperative imaging market is segmented into Hospitals and Others. Hospitals segment acquired highest revenue share in the intraoperative imaging market in 2021. This is because hospitals are increasingly implementing cutting-edge intraoperative imaging equipment to improve patient outcomes. For example, the first cerebral resection case employing a 3.0T high field intraoperative MRI equipment was done by the Xuanwu Hospital Neurosurgery Department China in April 2019, suggesting that the department has begun a new age of precision neurosurgery.
Component Outlook
By component, the intraoperative imaging market is fragmented into Systems, Software and Services. The systems segment recorded the largest revenue share in the intraoperative imaging market in 2021. It is due to the growing investment by governments on the adoption of various latest healthcare technologies and solutions. These systems are developed to fulfill the workflow demands of the surgical surroundings. In addition, these systems are utilized in a wide range of processes involving cranial, spine and orthopedics.
Application Outlook
Based on application, the intraoperative imaging market is classified into Neurosurgery, Orthopedic, ENT Surgery, Oncology Surgery, Trauma surgery/ emergency room, Cardiovascular and Others. The neurosurgery segment procured the highest revenue share in the intraoperative imaging market in 2021. Outcomes from intraoperative imaging are game-changing because they let neurosurgeons perform with greater precision, reduce the requirement for extra procedures, and shield patients from infection whereas being moved in and out of the operating theatre.
Regional Outlook
Region-wise, the intraoperative imaging market is analyzed across North America, Europe, Asia Pacific, and LAMEA. North America emerged as the leading region in the intraoperative imaging market with the maximum revenue share in 2021. With significant adoption of intraoperative imaging technology among important end users and quite well distribution networks for manufacturers and distributors of intraoperative imaging products, North America is a mature market.
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Siemens Healthineers AG are the forerunners in the Intraoperative Imaging Market. Companies such as Stryker Corporation, Medtronic plc, Koninklijke Philips N.V. are some of the key innovators in Intraoperative Imaging Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co., Koninklijke Philips N.V., Medtronic PLC, Siemens Healthineers AG (Siemens AG), Stryker Corporation, Fujifilm Holdings Corporation, Carl Zeiss Meditec AG (Carl Zeiss AG), Brainlab AG, Carestream Health, Inc. (Onex Corporation) and Ziehm Imaging GmbH
Recent strategies deployed in Intraoperative Imaging Market
Partnerships, Collaborations and Agreements:
Jun-2022: Medtronic came into a partnership with GE Healthcare, a subsidiary of American multinational conglomerate General Electric. This partnership aimed to enable GE Healthcare to combine clinically improved parameters to allow clinicians with precision monitoring for individualized care.
Apr-2022: Philips entered into a partnership with Prisma, the industry's most complete Cloud Native Application Protection Platform. This partnership aimed to improve healthcare across the enterprise and unleash the power of patient data. Through the Philips HealthSuite safeguard cloud platform at its foundation, Philips would strengthen enterprise interoperability, standardize patient monitoring, and boost innovation in enterprise imaging solutions to improve patient care and enhance clinical performance.
Apr-2021: Carestream Health formed a partnership with Ziehm Imaging, a medical device company. This partnership aimed to add a mobile C-arm into its rising innovative product portfolio. This surgical imaging system would improve Carestream's mobile and fluoroscopic product capabilities to benefit even more healthcare providers.
Apr-2021: Siemens Healthineers came into a partnership with Radlink, a leading medical device manufacturer. This partnership aimed to introduce Radlink HIP and Radlink TRAUMA Software Apps, which would offer a fully integrated, app-based solution for orthopedic surgeons to simplify intraoperative imaging guidance, verify component positioning and enhance efficiency during surgery.
Acquisitions & Mergers:
May-2022: Brainlab took over medPhoton, a Salzburg, Austria-based company. This acquisition aimed to introduce the mobile imaging robot, Loop-X. Brainlab invested in medPhoton, for the development of Loop-X and would become the exclusive distributor of the mobile imaging robot in the field of surgery.
Dec-2021: GE acquired BK Medical, a leader in advanced surgical visualization. Through this acquisition, GE Healthcare would add the fast-growing and relatively latest field of real-time surgical visualization to GE's pre- and post-operative Ultrasound offerings, developing an end-to-end offering via the complete continuum of care from diagnosis to therapy and beyond.
Jan-2021: Stryker took over OrthoSensor and its Verasense intraoperative sensor tech. This acquisition would improve the ortho giant's Mako robots. Patient recovery would become more active as a real-time measurement of main performance insights drives better results and patient satisfaction.
Jul-2020: Ziehm Imaging completed the acquisition of a leading developer of planning and imaging software tools for cardiovascular procedures, Therenva. This acquisition aimed to establish new standards in cardiovascular image fusion and 3D navigation.
Product Expansions & Product Launches:
Sep-2021: GE unveiled a new digital X-ray system Definium Tempo. This system would serve as a personal assistant to radiologists and technologists to decrease workflow burdens. Developed to act as an in-room command center, the Definium Tempo's tube-mounted console would offer all the functionality needed for protocol selection, patient selection, technique modification, and positioning setup.
Jun-2021: FUJIFILM Medical Systems released the industry's first Systems Integration platform. This platform is developed specifically to improve image and data integration in endoscopy suites. With these specially developed hardware and software configurations, this scalable solution would allow the multi-video & image routing and display offerings that GI physicians require along with performing advanced procedures.
Apr-2021: Royal Philips expanded its product line by introducing improved digital diagnostic and interventional neurovascular imaging solutions in the new Central Acute Services Building at Westmead Hospital in Sydney, Australia. This latest technology would offer up-to-date MR information at any time while surgical procedures that would assist clinicians to develop real-time adjustments to treatment in such procedures.
Geographic Expansions:
Mar-2022: Zeiss Medical Technology released INTRABEAM 600 device to deliver Intraoperative Radiation Therapy (IORT) in India. This device would deliver the least disruptive treatment method accessible to patients diagnosed with early-stage breast cancer.
Approval & Trials:
Jun-2022: Stryker got 510(k) clearance from the U.S. Food and Drug Administration for its Q Guidance System. The System, when utilized with the Spine Guidance Software, is an improved planning and intraoperative guidance system developed to allow open or percutaneous computer-assisted surgery.
Mar-2021: GE got 510(k) clearance from U.S. FDA for OEC 3D, a new surgical imaging system capable of 3D and 2D imaging. This product would establish a standard for interoperative 3D imaging with accurate volumetric images for the spine as well as the orthopedic process.
Market Segments covered in the Report:
By End-use
By Component
By Product
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research